Potential response to curcumin in infantile hemangioendothelioma of the liver.
A case of life-threatening infantile hemangioendothelioma of the liver in a 6-month-old infant treated successfully with the dietary supplement curcumin is reported, with 6-year follow-up. Implications for pathogenesis based on sites of action of curcumin are considered.
Hassell
Lewis A
LA
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA. lewis-hassell@ouhsc.edu
Roanh
Le Dinh
le D
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D003474:Curcumin / Q000627:therapeutic use*; D003952:Diagnostic Imaging; D019587:Dietary Supplements; D006390:Hemangioendothelioma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007223:Infant; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology; D012074:Remission Induction; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D003474:Curcumin